The U.S. Supreme Court this week signaled that it may be open to granting cert to a petition brought by a handful of biopharma companies challenging a Second Circuit opinion that allowed a class-action antitrust suit to proceed against them.
Bioworld
Original source
Rise launches its research-backed feature in three languages across the UAE and MENA
Phys.orgSee more headlines and perspectives on Google News
"I may sound arrogant, but I had thought I would not get complaints if I won," the Japanese scientist said of his achievement.
OCI will conduct joint semiconductor materials R&D with Jeonbuk National University, which is investing 64.2 billion won in a shared testbed.
Headlines and briefs on this site are for information only. Always verify details on the original source or live status page.
Read Disclaimer